http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2609234-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b7274a7a3c27f72f1d430c8ab34ef69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a82179a4b53376b046c01900b5ad06c6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B- |
| filingDate | 2004-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f6c29d30c46e020d42fda5e1994ab9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7cde8a69d89a82cf6c96bac32e4b586 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12a130ed5b4db401b6899ac4c8f0a303 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7858808f5b723bcaa028a2f03b7527b9 |
| publicationDate | 2017-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2609234-T3 |
| titleOfInvention | Prediction of the probability of cancer recurrence |
| abstract | A method of predicting the probability of disease-free survival of a patient with invasive ductal breast cancer, of negative ganglia, positive for ER, which comprises determining the level of expression of the STMY3 RNA transcript in a cell or tissue sample of breast cancer obtained from the patient, normalized against the level of expression of a reference set of RNA transcripts comparing the level of STMY3 normalized expression of the patient with a standardized level of STMY3 expression in a reference set of cancer tissue of breast that includes patients who (a) were alive without recurrence of local, regional or distant breast cancer, (b) were alive with recurrence of contralateral breast cancer, (c) were alive with a second primary cancer other than breast, or (d) died before breast cancer recurrence, in which an increased level of normalized expression of the patient's STMY3 indicates a reduced probability gives disease-free survival. |
| priorityDate | 2003-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 514.